UBS Maintains Neutral on Illumina, Raises Price Target to $133
Portfolio Pulse from Benzinga Newsdesk
UBS analyst John Sourbeer maintains a Neutral rating on Illumina (NASDAQ:ILMN) and raises the price target from $131 to $133.

August 07, 2024 | 2:36 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS analyst John Sourbeer maintains a Neutral rating on Illumina and raises the price target from $131 to $133.
The Neutral rating suggests that UBS does not expect significant short-term movement in Illumina's stock price. The slight increase in the price target from $131 to $133 indicates a modestly positive outlook but not enough to change the overall rating.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100